R Paternostro
Overview
Explore the profile of R Paternostro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paternostro R, Sieghart W, Trauner M, Pinter M
ESMO Open
. 2021 Jun;
6(4):100185.
PMID: 34139486
Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent and increasing liver disease, which encompasses a variety of liver diseases of different severity. NAFLD can lead to liver cirrhosis with...
2.
Mandorfer M, Scheiner B, Stattermayer A, Schwabl P, Paternostro R, Bauer D, et al.
Aliment Pharmacol Ther
. 2018 Jun;
48(4):451-459.
PMID: 29956823
Background: The rs738409 C>G p.I148M variant in the patatin-like phospholipase domain containing 3 (PNPLA3)-gene promotes triglyceride accumulation in hepatocytes and hepatic stellate cell activation and has previously been linked to...
3.
Schwarzer R, Kivaranovic D, Paternostro R, Mandorfer M, Reiberger T, Trauner M, et al.
Aliment Pharmacol Ther
. 2018 Mar;
47(8):1162-1169.
PMID: 29492989
Background: Sequential measurements of hepatic venous pressure gradient (HVPG) are used to assess the haemodynamic response to nonselective betablockers (NSBBs) in patients with portal hypertension. Aims: To assess the rates...
4.
Mandorfer M, Schwabl P, Paternostro R, Pomej K, Bauer D, Thaler J, et al.
Aliment Pharmacol Ther
. 2018 Jan;
47(7):980-988.
PMID: 29377193
Background: Elevated plasma von Willebrand factor antigen (vWF) has been shown to indicate the presence of clinically significant portal hypertension, and thus, predicts the development of clinical events in patients...
5.
Schwarzer R, Kivaranovic D, Mandorfer M, Paternostro R, Wolrab D, Heinisch B, et al.
Aliment Pharmacol Ther
. 2017 Nov;
47(1):86-94.
PMID: 29105115
Background: The amino sulphonic acid taurine reduces oxidative endoplasmatic reticulum stress and inhibits hepatic stellate cell activation, which might lead to reduction of portal pressure in cirrhosis. Aim: To assess...